Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction. | Front Oncol | 2021 | 33747934 | PubTator, text mining | PubMed |
| A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma. | Front Oncol | 2021 | 33747928 | PubTator, text mining | PubMed |
| Platelet Microparticle Controversial Role in Cancer. | Adv Pharm Bull | 2021 | 33747851 | PubTator, text mining | PubMed |
| Next generation of immune checkpoint inhibitors and beyond. | J Hematol Oncol | 2021 | 33741032 | PubTator, text mining | PubMed |
| Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients. | Transl Lung Cancer Res | 2021 | 33718022 | PubTator, text mining | PubMed |
| The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study. | Clin Transl Immunology | 2021 | 33717483 | PubTator, text mining | PubMed |
| Contribution of macrophages to fetomaternal immunological tolerance. | Hum Immunol | 2021 | 33715911 | PubTator, text mining | PubMed |
| Developmental exposure to chlordecone induces transgenerational effects in somatic prostate tissue which are associated with epigenetic histone trimethylation changes. | Environ Int | 2021 | 33711761 | PubTator, text mining | PubMed |
| Association of engagement in cultural activities with cause-specific mortality determined through an eight-year follow up: The HUNT Study, Norway. | PLoS One | 2021 | 33705441 | PubTator, text mining | PubMed |
| Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy. | J Med Chem | 2021 | 33683117 | PubTator, text mining | PubMed |
| Frailty and Quality of Life Among Community-Dwelling Older Adults. | Cureus | 2021 | 33680593 | PubTator, text mining | PubMed |
| The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance. | Pharmaceuticals (Basel) | 2021 | 33673265 | PubTator, text mining | PubMed |
| Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure. | Viruses | 2021 | 33672327 | PubTator, text mining | PubMed |
| The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. | Int J Mol Sci | 2021 | 33669204 | PubTator, text mining | PubMed |
| Quantifying Fetal Reprogramming for Biomarker Development in the Era of High-Throughput Sequencing. | Genes (Basel) | 2021 | 33668810 | PubTator, text mining | PubMed |
| Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges. | Int J Mol Sci | 2021 | 33668356 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma. | N Engl J Med | 2021 | 33657295 | PubTator, text mining | PubMed |
| Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity. | Cancer Immunol Res | 2021 | 33653716 | PubTator, text mining | PubMed |
| TAM kinases as regulators of cell death. | Biochim Biophys Acta Mol Cell Res | 2021 | 33647320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=56